The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min
Recent pair of lawsuits in lithium battery industry evince a pattern of companies using a ‘patent blocking’ strategy
Docket Navigator shows Hall has presided over nearly 190 patent cases as a judge and previously had patent litigation experience in private practice
Detailed analysis of representatives shows that while some tend to specialise in certain technologies, others act across a wider range of IPC sections
03 December 2020
Although life sciences companies would favour such a change, there are significant obstacles standing in the way of it happening
01 December 2020
Plans announced by British Prime Minister Boris Johnson will not change the IP reality, which is that Germany is the only serious game in town for auto in Europe
27 November 2020
Recent reforms have made it harder to obtain regulatory exclusivity for follow-on versions of rare disease treatments
24 November 2020
IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations
19 November 2020
IAM speaks to the tech transfer office of Oregon Health & Science University about the keys to success in university-industry deal-making
17 November 2020
As pre-grant challenges soar, Bombay court stresses that the right to oppose applications must not be abused
16 November 2020
In the way it has cleared up TC Heartland uncertainties relating to Hatch-Waxman litigation, the CAFC will have disappointed branded pharma companies
12 November 2020
Latest decision underscores the significance of changes to the country’s Patents Act
12 November 2020
IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation
10 November 2020
Unlock unlimited access to all IAM content
